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Strengths and limitations of this study
 ► To our knowledge, this is the most comprehensive 
systematic review and meta- analysis of contempo-
rary exercise- based cardiac rehabilitation for people 
with all manifestations of coronary artery disease.
 ► We conducted meta- analyses for 15 short- term and 
9 medium- term outcomes.
 ► We assessed risk of bias for all included studies us-
ing the Cochrane risk of bias tool.
 ► Data had a high level of statistical heterogeneity 
and the majority of studies were identified as having 
‘some concerns’ or ‘high risk’ in relation to the risk 
of bias assessment.
 ► Data were insufficient to analyse at distinct time- 
points, thus were pooled as short- term (1–6 months) 
or medium term (8–12 months).
AbStrACt
Objectives To determine the effect of contemporary 
exercise- based cardiac rehabilitation on generic and 
disease- specific health related quality of life for people 
with coronary artery disease.
Design Systematic review and meta- analysis.
Study eligibility criteria Randomised controlled trials 
testing exercise- based cardiac rehabilitation versus no 
exercise control that recruited after 31 December 1999. On 
30 July 2019, we searched the Cochrane Central Register 
of Controlled Trials, MEDLINE (Ovid), Embase (Ovid) and 
CINAHL (EBSCO) databases.
Study appraisal and synthesis Studies were screened 
for inclusion by two independent reviewers. Risk of bias 
was assessed using the Cochrane risk of bias tool. Data 
were reported as pooled means (95% CI for between- 
group difference.
results We identified 24 studies (n=4890). We performed 
meta- analyses for 15 short- term and 9 medium- term 
outcomes (36- Item Short Form Survey Instrument (SF-
36), EuroQol- 5D (EQ- 5D) and MacNew, a cardiac- specific 
outcome). Six short- term and five medium- term SF-36 
domains statistically favoured exercise- based cardiac 
rehabilitation. Only for two short- term SF-36 outcomes, 
‘physical function’ (mean difference 12.0, 95% CI 4.4 to 
19.6) and ‘role physical’ (mean difference 16.9, 95% CI 2.4 
to 31.3), did the benefit appear to be clinically important. 
Meta- analyses of the short- term SF-36 physical and 
mental component scores, EQ- 5D and MacNew and the 
medium- term SF-36 physical component score, did not 
show statistically significant benefits. Only two studies had 
a low risk of bias (n=463 participants).
Conclusions and implications of key findings There is 
some evidence of a short- term benefit of contemporary 
exercise- based cardiac rehabilitation on quality of life 
for people with coronary artery disease. However, the 
contemporary data presented in this review are insufficient 
to support its routine use.
IntrODuCtIOn
Coronary artery disease (CAD) is the leading 
cause of death worldwide.1 Over the past 
30 years, advances in interventional and 
secondary preventative cardiology have 
dramatically improved survival for people 
with CAD.2 3 In high- income countries, living 
with CAD, as a long- term condition, is now 
common. Of the 200 000 people who have 
a myocardial infarction annually in the UK, 
7 out of 10 survive. In 2018, there were over 
900 000 survivors of myocardial infarction 
and 2.3 million people living with CAD in the 
UK.4 This longevity after myocardial infarc-
tion represents a substantial and increasing 
burden on healthcare resource. There is a 
need for medical and lifestyle interventions 
that improve quality of life (QoL), maintain 
physical and psychosocial independence, 
and reduce long- term health and social care 
utilisation.
Cardiac rehabilitation (CR) has long been 
considered integral to the management 
of CAD.5 Exercise training in conjunction 
with cardiovascular risk factor management, 
psychosocial support and behaviour change 
(‘comprehensive’ CR) are the core compo-
nents of a complex health and lifestyle 
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intervention, which is unreservedly advocated in inter-
national guidelines and policy.6 7 Multiple meta- analyses 
incorporating trials spanning 1975–2018 reported favour-
able effects on functional capacity, hospital readmissions 
and mortality.8–12
Nevertheless, our 2018 systematic review (22 
randomised controlled trials (RCTs), N=4834), which 
only included RCTs of ‘contemporary’ exercise- based CR 
that recruited after the end of 1999, found that the CR 
programmes tested had no effect on all- cause mortality 
(risk difference 0.0, 95% CI −0.02 to 0.01), and only a 
small effect on hospital readmissions of borderline 
statistical significance.13 A 2018 network meta- analysis, 
while showing a reduction in mortality when including 
studies from 1975 to present day, found a non- significant 
reduction in mortality for studies published after 2001.12 
Existing data do not support the continued delivery of 
exercise- based CR in its current form where the intention 
is to reduce mortality or prevent hospital readmissions in 
CAD. For the continued use of these programmes to be 
justified for people with CAD, a paradigm shift in their 
stated aims is required.
In an ageing, multimorbid population, QoL, defined by 
WHO as ‘an individual’s perception of their position in life 
in the context of the culture and value systems in which 
they live and in relation to their goals, expectations, stan-
dards and concerns’,14 is a key priority for patients and 
healthcare providers. Patient- reported outcomes such as 
QoL are unique in providing the patient’s perspective 
on the efficacy of medical or lifestyle interventions.15 
Furthermore, any change is tangible and subjective, thus 
patients can themselves perceive and report any benefit 
associated with CR. Therefore, CR should perhaps be 
judged on its ability to add ‘life to years’ rather than 
‘years to life’. Nearly all previous systematic reviews have 
considered QoL data for exercise- based CR to be insuf-
ficient or unsuitable for meta- analysis due to consider-
able heterogeneity in outcome measures and reporting. 
A 2016 Cochrane review9 concluded that present data 
demonstrated improvement in at least one QoL domain 
in 65% of studies, and improvement in half or more of 
the reported domains in 25% of studies.
A 2018 meta- analysis (41 RCTs, N=11 747), pooling a 
range of measures and CR interventions from studies 
between 1975 and 2017, found that exercise training 
was associated with a small positive effect on QoL, but, 
overall, ‘psychosocial management’ was more effective.16 
A 2018 Cochrane review of exercise- based CR for angina 
pectoris was unable to draw conclusions on the impact of 
this intervention on QoL.17 Subsequently, a 2019 meta- 
analysis reported exercise to be effective in reducing 
anxiety and depression following myocardial infarction.18 
However, in a review of prospective cohort studies,19 
people with depression were four times less likely to 
participate in CR and seven times more likely to drop 
out. A 2019 systematic review (14 RCTs, N=1739) of CR 
for people following acute coronary syndrome, published 
when this paper was being prepared for submission, 
included eight studies in a meta- analysis and concluded 
that there were clinically important positive effects on two 
36- Item Short Form Survey Instrument (SF-36) domains 
at 6 months (role physical and general health) and one 
domain at 12 months (physical function).20
The objective of this systematic review and meta- 
analysis was to determine the effect of exercise- based CR 
on health- related QoL in all people with CAD, in the era 
of modern medical management.
MethODS
The methodology for our systematic review and meta- 
analysis adhered to the Preferred Reporting Items for 
Systematic Reviews and Meta- Analysis guidelines and the 
study was registered on PROSPERO (CRD42018110197).
Search strategy and methodology
First, we reviewed all studies included in the most recent 
Cochrane systematic review of exercise- based CR in coro-
nary heart disease.9 Second, we assessed the 93 studies 
listed as ‘excluded’ in the Cochrane review to identify any 
additional studies that met our inclusion criteria. Third, 
on 30 July 2019, we searched the Cochrane Central 
Register of Controlled Trials, MEDLINE (Ovid), Embase 
(Ovid) and CINAHL (EBSCO) databases using the 
strategy used in the Cochrane Systematic Review (online 
supplementary appendix 1).
Results from our three predefined sources were indi-
vidually examined to determine inclusion or exclusion. 
We retrieved abstracts, full- text manuscripts and supple-
mentary material where necessary, and hand searched 
reference lists of the subsequently included articles (and 
other recent systematic reviews) to identify additional 
studies of interest. Two reviewers (GMcG and RP) inde-
pendently undertook screening of the resultant citations, 
abstracts and manuscripts, with disputes mediated by a 
third reviewer (MU). Where data were missing or inap-
propriately presented, we requested additional informa-
tion from lead and corresponding authors by email, on 
multiple occasions.
Study inclusion criteria
Our overall aim was to identify RCTs testing an exercise- 
based CR intervention against non- exercise usual care, 
with QoL as an outcome measure, which recruited after 
31 December 1999. The rationale for excluding studies 
recruiting prior to the year 2000 is detailed elsewhere.13 
Briefly, we defined contemporary CR as postdating the 
widespread adoption of primary percutaneous coronary 
intervention and the ‘modern’ pharmacology outlined in 
the Joint British Society recommendations for the Preven-
tion of Coronary Heart Disease in Clinical Practice.21 
Including studies that recruited after the end of 1999 
allowed sufficient time for these innovations to become 
commonplace.
Design
We identified RCTs testing an exercise- based CR inter-
vention against non- exercise usual care, which reported 
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outcomes at any time- point following completion of the 
intervention. Previous reviews assessing mortality and 
hospitalisation have only included studies with at least 
6 months follow- up.9 For QoL indicators, we considered 
outcome measures at any time- point following comple-
tion of CR to be of interest. We excluded abstracts, confer-
ence proceedings, theses and non- English language 
publications.
Participants
We included all studies where participants either had CAD 
confirmed with coronary angiography, had a diagnosis 
of angina pectoris, had undergone coronary revascular-
isation via either percutaneous coronary intervention 
or coronary artery bypass grafting, or had sustained a 
myocardial infarction.
Interventions
We defined interventions as exercise- based CR under-
taken with or without supervision as a hospital inpatient, 
as a hospital outpatient, in a community venue or at 
home. Furthermore, the exercise programme could have 
been delivered in isolation or in combination with other 
educational, behavioural or psychosocial components 
constituting a ‘comprehensive’ multicomponent CR 
programme. We defined usual care as any intervention 
delivered to people with CAD that did not include a struc-
tured exercise component, that is, disease- specific educa-
tion, smoking cessation, dietary advice or psychosocial 
support, delivered without supervised exercise training. 
We excluded studies in which both groups had completed 
a CR exercise training intervention prior to randomisa-
tion to an exercise intervention or a non- exercise control.
Outcome measures
Data were extracted from studies reporting between- 
group difference in QoL, collected with a generic or 
cardiovascular disease- specific, validated measure, for 
example, the SF-36 at any time- point post- CR. Measures 
were considered to be validated if there was evidence 
in the peer- reviewed literature that the instrument had 
been psychometrically tested for reliability, validity and/
or sensitivity.
Data extraction and statistical analysis
Any QoL data available at baseline and follow- up were 
extracted from studies that met the inclusion criteria. 
For each of the exercise- based CR and non- exercise usual 
care arms, the data extracted at each visit were the mean 
QoL score and the SD of the QoL score. If the means 
and SDs were not explicitly reported, they were extracted 
from line graphs (where possible) or derived from CIs. 
The SDs were computed assuming the CIs were obtained 
taking the point estimates to be normally distributed.
To pool the results from all studies for each QoL 
measure at a particular time- point, we fitted a random- 
effects meta- analysis model in the R statistical program.22 
The pooled results were summarised in forest plots. 
Where means and SDs in each arm were available for all 
included studies, the ‘meta’ package, with a command 
that requires specifying the mean and SD for each arm, 
was used to perform the meta- analysis.23 For the short- 
term SF-36 Mental Health Component and Physical 
Health Component scores, two studies24 25 reported the 
mean difference and the SE, thus it was not possible to 
extract the means and SDs. Therefore, the ‘metafor’ 
package, with a command that requires specifying mean 
difference and SE for each study, was used to perform the 
meta- analysis.26 This was the same approach to extracting 
EuroQol- 5D (EQ- 5D) data in another study.27 In these 
cases, if a study reported means and SDs, these were used 
to calculate the mean difference and the SE.
There were two options for defining the outcomes to be 
used to compare usual care and exercise- based CR at any 
particular time- point: (1) taking the outcome as the QoL 
score at each time- point or (2) taking the outcome as the 
change in QoL score from baseline. Some studies did not 
report baseline values or changes, and so the former defi-
nition was chosen. This enabled the inclusion of more 
studies in the meta- analyses.
Assessment of risk of bias
We performed a risk of bias assessment for all studies 
included in our meta- analyses using V.2 of the Cochrane 
risk of bias tool for randomised trials.28 Accordingly, 
risk of bias was assessed for general trial procedures and 
specifically for the QoL outcome of interest. Each trial 
was assessed against five domains of bias: (1) bias arising 
from the randomisation process; (2) bias due to devia-
tions from intended interventions; (3) bias due to missing 
outcome data; (4) bias in measurement of the outcome 
and (5) bias in selection of the reported result. As per 
the Cochrane Handbook,28 an overall risk of bias score of 
‘low’, ‘some concerns’ or ‘high’ was determined for each 
trial. ‘Low’ risk of bias was implied when all domains were 
scored ‘low’. ‘Some concerns’ was implied when at least 
one domain was scored as ‘some concerns’. ‘High’ risk of 
bias was implied when at least one domain was scored as 
‘high’, or multiple domains were scored ‘some concerns’. 
All studies were assessed independently by two reviewers 
(GMcG and RP) with discrepancies resolved by a third 
(MU).
Patient and public involvement
There was no patient and public involvement in this 
systematic review.
reSultS
Studies retrieved
Thirteen studies in the Cochrane review24 27 29–39 met our 
criteria and one study was identified from the Cochrane 
excluded studies list.40 Of 32 studies retrieved for full 
evaluation from our updated literature search, 3 were 
excluded as they were not RCTs, 14 because they did not 
use QoL as an outcome measure, 3 because participants 
completed structured CR prior to being randomised to a 
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Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) diagram. CR, cardiac rehabilitation; 
QoL, quality of life; RCT, randomised controlled trial.
CR intervention or control group and 2 because they did 
not qualify as ‘exercise- based CR’: this left 10 studies.25 41–49 
A total of 24 studies (N=4,890) were suitable for inclusion 
(figure 1).
All studies reported QoL using at least one validated 
measure, and seven studies used two measures. Six 
different generic measures were used: SF-36 (14 studies), 
12- item Short Form Survey (SF-12, 2 studies), EQ- 5D (2 
studies) and 20- item Short Form Survey (SF-20), 15 D 
Questionnaire, Time Trade Off Questionnaire 1 study 
each. Six cardiac- specific measures were used: MacNew 
QoL Questionnaire (four studies), HeartQoL Ques-
tionnaire (two studies) and Duke Activity Status Index 
(DASI), the Seattle Angina Questionnaire, Quality of 
Life Index- cardiac version III and Myocardial Infarction 
Dimensional Assessment Scale all one study each.
Data were reported at varying time- points and 
presented in numerous statistical formats, thus reducing 
the number of point estimates we could reliably include 
in each analysis. We contacted authors from eight 
studies24 27 30 33 37 40 42 44 to request provision of data in 
a format consistent with our meta- analysis protocol. A 
response was received from two authors stating that the 
data were not available.37 42
We performed meta- analyses at two time- points: short- 
term (immediately postintervention, or as soon as possible 
thereafter, up to 6 months (1–6 months)) and medium- 
term (8–12 months postrandomisation). This allowed us 
to assess both the immediate postintervention effect of 
exercise- based CR, and the long- term effect. Where data 
were reported twice within the short- term timescale (ie, 3 
and 6 months),35 data recorded closest to the end of the 
intervention period were included in the meta- analysis. 
We pooled data from studies using SF-36 and SF-12, 
henceforth SF-36. Data were sufficient to undertake meta- 
analysis for three measures: the SF-36 (eight domains and 
physical component score for the short- term and medium- 
term time- points, plus the physical component score for 
the short- term time- point only), the EQ- 5D (short- term 
only) and the MacNew (short- term only).
excluded studies and erroneous data
Despite the SF-20 Questionnaire being broadly a deriv-
ative of the SF-36 and SF-12, we did not include one 
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study29 in the SF-36 analyses as the questions and scoring 
algorithms are not sufficiently comparable. One study46 
described exercise performed as an inpatient prior to 
randomisation. We included this study as the prerando-
misation exercise involved gentle mobilisation only, as 
opposed to a structured CR exercise intervention, thus 
fitting with our inclusion criteria. For the same reasons, 
we excluded a study50 in which both groups did complete 
a structured exercise- based CR intervention prior to 
randomisation. Following full- text retrieval, we excluded 
two studies51 52 which, although aimed to increase partic-
ipation in physical activity, employed general lifestyle 
interventions as opposed to exercise- based CR as defined 
in our protocol.
For one study,41 only selected SF-36 variables were 
reported; physical function domain, and mental compo-
nent score and physical component score. We were able 
to include the physical function domain data but were 
unable to include the mental and physical component 
score subscales data as the mean values reported were 
out of range for the measure. Data from another study53 
reporting the SF-36 could not be accurately extracted 
from a line- graph, and for another,31 could not be meta- 
analysed, as the way in which the data were reported 
meant multiple assumptions would have been required. 
For the EQ- 5D, we performed meta- analysis at the short- 
term time- point using data from two studies.27 34 We could 
not include EQ- 5D data from one study,47 as all the infor-
mation required for a meta- analysis was not reported. For 
another study,49 mean values were out of the measure-
ment range for the MacNew Questionnaire, thus, while 
otherwise the study met our inclusion criteria, the data 
could not be included. Online supplementary appendix 2 
shows how data were extracted and included in the meta- 
analyses where means or SDs were not explicitly reported.
Sample size, gender, age and study origin
We included 4890 randomised participants in our anal-
yses. Of the 24 studies, 21 included both male and female 
participants, 1 study included males only33 and 1 study 
did not specify43 the gender of participants recruited 
(table 1). The mean age of participants in each study 
was 62 years, range 53–77 years. One study reported an 
incorrect mean age.49 Three studies were conducted in 
the UK,36 40 42 9 elsewhere in Europe24 25 29 30 34 38 44 45 47 and 
12 outside Europe.27 31–33 35 37 39 41 43 46 48 49
Participant diagnosis of coronary artery disease
Participant diagnoses, that is, manifestations of CAD, was 
described in all studies (table 1). Fourteen trials included 
participants with a range of diagnoses including CAD 
confirmed with coronary angiography, angina pectoris, 
myocardial infarction, percutaneous coronary interven-
tion and/or coronary artery bypass grafting.27 29–32 34 37–41 44 47 
Four studies included participants following myocardial 
infarction only,24 35 36 46 and one study, angina pectoris 
only.42 Five studies recruited participants ‘following 
coronary artery bypass grafting’25 33 43 45 49 and one study 
‘after percutaneous coronary intervention’.48
treatment received
Twelve studies included participants who had been revas-
cularised by percutaneous coronary intervention or coro-
nary artery bypass grafting following a recent or past 
cardiac event24 27 31 32 35–38 40–42 44 (table 1). Five studies 
recruited participants following percutaneous coronary 
intervention only29 35 39 46 48 and five studies recruited 
participants following coronary artery bypass grafting 
only.25 33 43 45 49 It was unclear in two studies whether 
participants had been revascularised before randomisa-
tion and, if so, by which specific procedure.30 47
Medication
Thirteen studies provided a full description of medica-
tion (table 1). Six studies referred to medication but 
provided no specific detail.32 33 42 47–49 One study reported 
beta- blocker usage without reference to other medica-
tions.41 The remaining four studies did not provide any 
information about medication.27 30 34 43
recruitment period
Thirteen studies recruited participants after 31 December 
1999 (table 1). In one study, participants were recruited 
between 1997 and 2000.36 On the basis that participant 
diagnosis, treatment received and co- existing medical 
therapies indicated ‘contemporary’ medical care, it was 
agreed by all reviewers to include this study. This is consis-
tent with the approach used in our previous review of 
survival.13 For the remaining 10 studies, a recruitment 
period could not be clearly determined from the manu-
scripts. However, given the description of participant 
diagnosis, medical treatment, pharmacological therapies 
and CR interventions, it was agreed by all reviewers that 
they met our criteria for inclusion.
Content of the interventions
Intervention content varied considerably between studies 
(tables 1 and 2). Nineteen studies compared exer-
cise training in combination with additional therapies 
(education and psychosocial components), two studies 
compared exercise training as a stand- alone interven-
tion,29 41 while one study combined exercise and relax-
ation.43 The exercise components of the interventions 
varied with respect to the setting, training modality, dura-
tion, session length, frequency and intensity. The majority 
of studies incorporated walking and/or cycling as the 
main exercise modality, delivered for a period ranging 
from 4 to 12 months, in either an inpatient, home- based 
or out- patient setting.
Overall effects of interventions
SF-36 short-term
We included data from four trials (N= 560) for six SF-36 
domains27 35 37 43 and data from five trials for the phys-
ical function27 35 37 41 43 and bodily pain27 35 37 40 43 domains 
(N= 596 and 600) in our meta- analyses (figure 2A). The 
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Figure 2 (A) Meta- analysis for quality of life (36- Item Short Form Survey Instrument (SF-36) domains) at the short- term time- 
point. (B) Meta- analyses of SF-36 aggregate scores (MCS, mental component score; PCS, physical component score and total) 
at the short- term time- point.
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data were heterogeneous (I2 >80% for seven of eight 
domains). Point estimates favoured exercise- based CR in 
all domains. In six domains, physical function (12.0 (95% 
CI 4.4 to 19.6)), role physical (16.9 (2.4 to 31.3)), general 
health (4.6 (1.9 to 7.2)), vitality (7.6 (1.2 to 14.0)), social 
function (10.9 (2.0 to 19.8)) and mental health (4.4 (0.3 
to 8.6)), these differences were statistically significant.
We included data from three trials (N=371)24 25 45 that 
reported the physical and mental component scores of 
the SF-36. No statistical significant differences were found 
(figure 2B). We meta- analysed data from two studies 
(N=112)33 43 reporting an overall SF-36 score. A statisti-
cally significant benefit (24.9 (95% CI 16.7 to 33.2)) was 
found.
SF-36 medium-term
In our meta- analyses, we included data from three trials 
(N= 1870)36 37 48 for six SF-36 domains, and data from 
four trials (N=1996)30 36 37 48 for the general health and 
vitality domains. The data were less heterogeneous 
than the short- term data (I2 >80% for three of eight 
domains). Point estimates favoured exercise- based CR in 
all domains. In five domains, physical function (4.0 (95% 
CI 0.7 to 7.3)), role physical (6.9 (0.2 to 13.6)), general 
health (6.0 (0.9 to 11.1)), vitality (6.5 (0.6 to 12.3)) and 
social function (6.2 (0.9 to 11.4)), these differences were 
statistically significant (figure 3A).
We included data from two trials (N=478)30 38 that 
reported the mental component score of the SF-36, one 
of which also reported the physical component score (N = 
372).38 No statistically significant differences were found 
(figure 3B).
EuroQol-5D
We included data from two studies that reported short- 
term outcomes for the EQ- 5D (N=254).27 34 The point esti-
mate favoured exercise- based CR but was not statistically 
significant (figure 4A). No studies reported medium- term 
outcomes for the EQ- 5D.
MacNew Questionnaire
We included data from three studies that reported short- 
term outcomes for the MacNew subscales (N=316, 316 
and 318).39 42 46 Two of these also reported an overall 
score (N=242).39 46 All point estimates favoured exercise- 
based CR but there were no statistically significant differ-
ences (figure 4B).
Other measures
Eight other QoL measures were each reported by one 
study. Statistically significant benefits were found in seven 
out of eight domains of the MOS (Medical Outcomes 
Study 20- Item Short Form Survey) 20 at 12 months, the 
EQ- 5D mobility subscale at 12 months, the DASI at 4 and 
12 months, the Seattle Angina Questionnaire emotional 
score at 6 weeks, the overall Quality of Life Index- cardiac 
version III and the same five out of seven of MIDAS 
subscales at 3 and 12 months (online supplementary 
appendix 3).
risk of bias assessment
We assessed two of the studies included in our meta- 
analyses as having a low risk of bias (N=463),25 27 nine as 
having ‘some concerns’ (N=2493)24 34–36 38 42 45 46 48 and the 
remaining seven as high risk (N=671)30 33 37 39–41 43 (online 
supplementary appendix 4, figure 5). Methodolog-
ical issues leading to a classification of high risk of bias 
related primarily to two domains: (1) deviations from the 
intended interventions and (2) missing outcome data. 
For the former, lack of intention- to- treat analysis and 
inadequate blinding were common issues. For the latter, 
high loss to follow- up was a common issue.
DISCuSSIOn
We performed meta- analyses of 15 short- term and 9 
medium- term outcomes. With such a large number of 
comparisons, some statistically significant findings could 
be expected due to random chance. Two- thirds of the anal-
yses (16/24) were for the eight SF-36 domains. Multiple 
individual SF-36 domain scores showed statistically signif-
icant positive results from exercise- based CR, both in the 
short- term and medium- term. However, the domains in 
which a statistically significant effect was observed were 
different for the short- term and medium- term outcomes. 
These findings should be interpreted with considerable 
caution; the quality of the included trials was generally 
poor and there was substantial statistical heterogeneity. 
Nevertheless, the overall picture for all domains at both 
time points favours exercise- based CR, suggesting that 
there may be an overall benefit on SF-36 domain scores.
The meta- analyses of the SF-36 physical and mental 
component scores at 12 months, in contrast, did not 
show any benefit from exercise- based CR. We have for 
completeness included a meta- analysis of an overall SF-36 
score showing a clear benefit from exercise- based CR. The 
SF-36 overall score is not an accepted metric.54 55 While 
these studies met our inclusion criteria, we attach very 
little weight to this finding because of the non- standard 
approach to the analysis of the SF-36.
The meta- analysis for the MacNew Questionnaire, a 
cardiovascular disease- specific outcome, did not find any 
statistically significant short- term benefit. Nevertheless, 
for all three domains, the direction of change favoured 
exercise- based CR. We found no data on the medium- 
term or long- term benefits of exercise- based CR on 
cardiovascular disease- specific QoL. Similarly, the meta- 
analysis of EQ- 5D data found a non- significant difference 
in favour of exercise- based CR.
A broadly similar pattern was seen in the trials not 
suitable for meta- analysis, with some statistically signifi-
cant findings on certain outcomes but with no consistent 
support for benefit. Taking all of these data into account, 
our interpretation is that there is some evidence of a bene-
ficial effect of exercise- based CR on QoL in the short- term 
and insufficient data to comment on the medium- term 
or long- term benefits. In combination, therefore, under-
taking an exercise programme, risk factor modification 
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Figure 3 (A) Meta- analysis for quality of life (36- Item Short Form Survey Instrument (SF-36) domains) at the medium- term 
time- point. (B) Meta- analyses of SF-36 aggregate scores (MCS and PCS) at the medium- term time- point.
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Figure 4 (A) Meta- analysis for EuroQol- 5D (EQ- 5D) at the short- term time- point. (B) Meta- analysis for quality of life (MacNew) 
at the short- term time- point.
and behavioural education as part of a comprehensive CR 
programme may have some impact on individual domains 
of health- related QoL.
Our observations are limited by the quality of the 
included studies and the heterogeneity of both the trial 
participants and the interventions tested. We cannot 
exclude the possibility that there are subgroups for whom 
exercise- based CR is effective. To contextualise this obser-
vation, data from our previous review of mortality13 in 
exercise- based CR should be considered (mortality was 
not assessed in the current review). The review was crit-
icised for not considering the potentially greater benefit 
for those who adhere to treatment.56 Since the overall 
effect on mortality in our previous review was zero, any 
reduced mortality in the subgroup that adhered, would 
inevitably mean an equal increase in mortality in partici-
pants who did not adhere. In contrast, given the positive 
effect of exercise- based CR on QoL in the current anal-
yses, it is plausible that poor adherence to the interven-
tion is attenuating the benefits. If there is a zero effect in 
those who do not adhere, there may be a worthwhile effect 
in those who do adhere. None of our included studies 
presented an analysis that would allow the effect size in 
adherent participants to be estimated appropriately.57 
The approach of comparing outcomes in the adherent 
group with overall outcomes in the control group used 
 o
n
 June 17, 2020 at BVA. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-036089 on 7 June 2020. Downloaded from 
16 McGregor G, et al. BMJ Open 2020;10:e036089. doi:10.1136/bmjopen-2019-036089
Open access 
Figure 5 Risk of bias assessment. Does exercise- based cardiac rehabilitation improve quality of life in coronary artery 
disease? A contemporary systematic review and meta- analysis.
by some authors25 is potentially misleading. An appro-
priate approach, such as a complier average causal effect 
analysis, would adjust for non- compliance, thus providing 
more reliable results.
Our previous review13 has been criticised for including 
the RAMIT (Rehabilitation After Myocardial Infarc-
tion Trial) trial.36 Other recent reviews20 using the same 
recruitment period criteria as us, excluded the RAMIT 
trial whose recruitment straddled the end of 1999. In a 
post hoc sensitivity analysis we excluded RAMIT data. It 
did not materially affect our conclusions (online supple-
mentary appendix 5). For completeness, we also provide 
our previous mortality analysis with RAMIT excluded 
(online supplementary appendix 6). Again, this does not 
materially change our previous conclusions.
Post hoc, to inform a discussion on the clinical rele-
vance of our findings, we searched unsuccessfully for 
established values of clinically important between- group 
differences, following CR, for the outcomes included in 
our meta- analyses. For the SF-36, the minimal clinically 
important within- person change has been reported as 
an increase in any domain score of three to five points.58 
All of our statistically significant differences in the SF-36 
domains met this threshold. However, caution is strongly 
advised with this arbitrary value as the clinically important 
within- person change varies considerably, dependent on 
diagnosis and duration and severity of disease, among 
other confounders.59 60 Therefore, we looked for values 
of a clinically important within- person change in SF-36 
domains following CR. On the basis that an improve-
ment equating to half of the within- person change can 
be considered a worthwhile outcome for an appreciable 
number of people,61 we set this as a criterion for a clin-
ically important between- group difference. Usefully, for 
our current purpose, a heart disease expert consensus62 
suggested SF-36 domain- specific changes that should be 
considered minimal, moderate and large for an indi-
vidual. Minimal changes ranged from 15 to 25 points, and 
moderate changes from 25 to 50 points (online supple-
mentary appendix 7). Using this approach, the only clini-
cally important differences in the SF-36 domains were the 
short- term effects on ‘physical function’ and ‘role phys-
ical’. These are above, or close to half of, the consensus 
values for a moderate change. No other point estimates 
met the criteria for a clinically important change.
For the MacNew Questionnaire, a within- person change 
of 0.5 points for any specific domain or the overall score 
has been proposed.63–65 Using the same approach, we 
would set a between- group difference of 0.25 points as a 
clinically important benefit. Although none of the anal-
yses was statistically significant, the point estimates for 
physical and emotional subscales and the overall score are 
consistent with a clinically important short- term benefit 
on the MacNew Questionnaire.
Strengths and limitations
We identified 24 studies, 18 of which we could include in 
meta- analyses. Due to wider inclusion criteria in terms of 
time- points for outcome reporting, this is >14 studies iden-
tified (8 meta- analysed) in another recent review.20 Also, 
our search date was more recent, and we included studies 
testing exercise- based CR interventions in all manifesta-
tions of CAD rather than just those with acute coronary 
syndrome±revascularisation, angina or angiographically 
documented CAD. We did, however, exclude one study53 
from our meta- analyses that was included by the previous 
authors. We were unable to extract data from the line 
graph, and values presented in the text were not between 
groups differences so could not be used. We also differ 
from the other recent review in our interpretation of a 
clinically important benefit for the SF-36. This is because 
we used consensus values for minimal and moderate 
change62 to define clinical importance, rather than the 
smallest measurable change in an SF-36 domain. We 
would interpret their findings as showing that there were 
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no clinically important benefits on any SF-36 domains 
and that only role physical achieved a minimal benefit.
Given the heterogeneity and paucity of data included 
in our review, strengths and weaknesses should be consid-
ered. We performed rigorous and transparent system-
atic review, with meta- analysis where possible. Where 
there was any doubt as to data compatibility, we opted 
to exclude studies from the analysis, helping to ensure 
the integrity of the results. We included only data from 
studies recruiting after 31 December 1999 to ensure 
that findings were applicable in the era of contemporary 
medical care. Defining the era of contemporary medical 
care can be problematic due to difficulties in identifying 
exactly when data were collected for each trial, and the 
nature of medical practice at the time. Therefore, it is not 
possible to be certain that included and excluded trials 
exactly match our criteria for what constitutes contem-
porary medical care. However, meticulous examination 
of each trial provides a high level of confidence that the 
most appropriate studies have been included.
Our findings are limited by a number of inconsisten-
cies in the CR literature and data. While baseline data 
were always collected prior to randomisation, follow- up 
data were reported at varying times postrandomisation. 
Our short- term data included studies reporting their 
first follow- up at anything between 1 and 6 months. 
Equally, our medium- term data covered studies reporting 
between 8 and 12 months. Data were too scarce and 
heterogeneous to assess time- points more accurately. It is 
also worth noting that only 5/24 analyses in our review 
included studies using CAD- specific QoL measures. It is 
possible that generic QoL instruments are insufficiently 
sensitive to detect change in people with CAD. Disease- 
specific tools are more likely to accurately reflect QoL in 
this population.
Exercise interventions and other core components of 
comprehensive CR varied widely in their composition and 
delivery, and these may have fallen short of what would 
be considered ‘optimal’ or ‘gold standard’ care. Equally, 
usual care was inconsistent which may dilute any benefit 
associated with exercise- based CR. Furthermore, the 
overall quality of studies included in our meta- analyses 
was poor, with the majority scoring ‘some concerns’ or 
‘high’ on the risk of bias assessment. Numerous sources 
of potential bias were identified including poor reporting 
of key methodological information such as randomisa-
tion, blinding and statistical analyses.
Data reporting in some studies is a potential source 
of bias. First, results from one study46 showed a vastly 
superior improvement in MacNew QoL scores compared 
with others39 42 in the short- term analysis. Second, 
one study33 reported only the total score for the SF-36 
at 6 months; this is not a validated or recommended 
measure.54 55 Third, for one study,38 we only included 
n=372 (58%) participants who had IHD at 12 months 
follow- up, however, the SF-36 values included a propor-
tion of participants with heart failure (12%) or at high 
risk of ischaemic heart disease (30%). However, this only 
affected the medium- term data for SF-36 MCS and PCS, 
as these were the only data reported in the trial. Finally, 
we could not perform a meta- analysis for the SF-36 PCS 
at 12 months in one study30 as an exact p value was not 
provided.
COnCluSIOnS
For people with CAD participating in exercise- based CR, 
our meta- analyses show statistically significant improve-
ments in multiple individual SF-36 domain scores, but 
only 2/24 comparisons (both short- term outcomes) can 
be deemed clinically important. Exercise- based CR shows 
promise as an approach to improve QoL for people with 
CAD. However, the contemporary data presented in this 
review are insufficient to support its routine use. Given 
the critical importance of QoL to people living with long- 
term conditions, future research should optimise CR 
programmes to target improvement in QoL domains.
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